Consequence of neo-adjuvant chemotherapy on morphology of breast carcinoma: A systematic evaluation

被引:4
作者
Chakrabarti, S. [1 ]
Mandal, P. K. [2 ]
Chowdhury, Roy A. [3 ]
Das, S. [3 ]
机构
[1] ESI PGIMSR, Dept Pathol, Manicktala, W Bengal, India
[2] NRS Med Coll & Hosp, Dept Hematol, Kolkata, W Bengal, India
[3] RG Kar Med Coll, Kolkata, W Bengal, India
关键词
Breast carcinoma; histopathology; morphology; neo-adjuvant chemotherapy; pathologic response; PREOPERATIVE CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; PATHOLOGICAL RESPONSE; CANCER; TUMOR;
D O I
10.4103/0019-509X.180850
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Neo-adjuvant chemotherapy (NAC) in locally advanced breast cancer is the present trend. Following NAC, a considerable alteration of morphology occurs in the tumor. AIMS: To study effects of NAC on morphology of breast carcinoma and to evaluate the pathologic response (PR). MATERIALS AND METHODS: A total of 39 surgically resected mastectomy specimens of patients of invasive locally advanced breast carcinoma who received NAC were evaluated for macroscopic and microscopic (by routine stains and immunohistochemistry) alteration of morphology. RESULTS: Macroscopically well-defined tumor noted in 25 cases (64.1%) and in the rest (14 cases, 35.9%), only fibrotic areas identified. Microscopic examination identified malignant cells in 29 (74.4%), significant chronic inflammation in 24 (61.5%), hyalinized fibrosed stroma in 25 (64.1%) and necrosis in 11 (28.2%) cases. Immunohistochemistry assisted in differentiating malignant cells from histiocytes. In 15 cases (38.5%), axillary lymph nodes isolated where fibrosis seen in 12 (30.8%) and malignant cell in 8 (20.5%) cases. In 34 cases where the pre-treatment biopsy were available, complete pathologic response (pCR) and partial pathologic response (pPR) were achieved in 7 (20.6%) and 23 (67.4%) cases respectively. DISCUSSION: Protocol of systematic evaluation of morphological changes is different in cases of a patient treated by NAC. Nature of malignancy was difficult to categorize as morphology of typical breast carcinomas were altered. Sometimes, immunohistochemistry is advantageous as routine H and E stains are not sufficient to isolate malignant cells in fibrotic and necrotic areas. Appropriate morphological evaluation of the mastectomy specimen is absolutely crucial for assessment of PR and subsequent management.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 23 条
  • [1] HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer
    Arens, N
    Bleyl, U
    Hildenbrand, R
    [J]. VIRCHOWS ARCHIV, 2005, 446 (05) : 489 - 496
  • [2] American joint committee on cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome
    Carey, LA
    Metzger, R
    Dees, EC
    Collichio, F
    Sartor, CI
    Ollila, DW
    Klauber-DeMore, N
    Halle, J
    Sawyer, L
    Moore, DT
    Graham, ML
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (15): : 1137 - 1142
  • [3] Neoadjuvant chemotherapy in breast cancer
    Charfare, H
    Limongelli, S
    Purushotham, AD
    [J]. BRITISH JOURNAL OF SURGERY, 2005, 92 (01) : 14 - 23
  • [4] INFLAMMATORY BREAST-CANCER - PILOT-STUDY OF INTENSIVE INDUCTION CHEMOTHERAPY (FEC-HD) RESULTS IN A HIGH HISTOLOGIC RESPONSE RATE
    CHEVALLIER, B
    ROCHE, H
    OLIVIER, JP
    CHOLLET, P
    HURTELOUP, P
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (03): : 223 - 228
  • [5] COMBINED CHEMOTHERAPY-RADIOTHERAPY APPROACH IN LOCALLY ADVANCED (T3B-T4) BREAST-CANCER
    DELENA, M
    ZUCALI, R
    VIGANOTTI, G
    VALAGUSSA, P
    BONADONNA, G
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1978, 1 (01) : 53 - 59
  • [6] Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: Influence of hormonal status and HER-2 in breast cancer - A study from the IMPACT trialists
    Dowsett, M
    Ebbs, SR
    Dixon, JM
    Skene, A
    Griffith, C
    Boeddinghaus, I
    Salter, J
    Detre, S
    Hills, M
    Ashley, S
    Francis, S
    Walsh, G
    Smith, IE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) : 2477 - 2492
  • [7] Pathobiology of preoperative chemotherapy - Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-18
    Fisher, ER
    Wang, JP
    Bryant, J
    Fisher, B
    Mamounas, E
    Wolmark, N
    [J]. CANCER, 2002, 95 (04) : 681 - 695
  • [8] Neoadjuvant Chemotherapy and Targeted Therapy in Breast Cancer: Past, Present, and Future
    Gampenrieder, Simon P.
    Rinnerthaler, Gabriel
    Greil, Richard
    [J]. JOURNAL OF ONCOLOGY, 2013, 2013
  • [9] Update on locally advanced breast cancer
    Giordano, SH
    [J]. ONCOLOGIST, 2003, 8 (06) : 521 - 530
  • [10] Quality control in the histopathology laboratory: An overview with stress on the need for a structured national external quality assessment scheme
    Iyengar, Jayaram N.
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2009, 52 (01) : 1 - 5